Titre :
  • Proliferation and estrogen signaling can distinguish patients at risk for early versus late relapse among estrogen receptor positive breast cancers.
Auteur : Bianchini, Giampaolo ; Pusztai, Lajos ; Karn, Thomas ; Iwamoto, Takayuki ; Rody, Achim ; Kelly, Catherine M ; Müller, Volkmar ; Schmidt, Marcus ; Qi, Yuan ; Holtrich, Uwe ; Becker, Sven ; Santarpia, Libero ; Fasolo, Angelica ; Del Conte, Gianluca ; Zambetti, Milvia ; Sotiriou, Christos ; Haibe-Kains, Benjamin ; Symmans, W Fraser ; Gianni, Luca
Informations sur la publication : Breast cancer research, 15, 5, (page R86)
Statut de publication : Publié, 2013-09
Sujet CREF : Cancérologie
Médecine pathologie humaine
Sciences bio-médicales et agricoles
Mots-clés MeSH : Adult
Aged
Antineoplastic Agents, Hormonal -- therapeutic use
Breast Neoplasms -- drug therapy -- genetics -- metabolism -- mortality -- pathology
Cell Proliferation
Chemoradiotherapy, Adjuvant
Estrogens -- genetics -- metabolism
Female
Follow-Up Studies
Gene Expression Profiling
Gene Expression Regulation, Neoplastic
Humans
Middle Aged
Mitosis
Neoplasm Grading
Neoplasm Metastasis
Neoplasm Recurrence, Local
Neoplasm Staging
Prognosis
Receptors, Estrogen -- genetics -- metabolism
Risk
Signal Transduction
Tamoxifen -- therapeutic use
Tumor Markers, Biological -- genetics -- metabolism
Note : JOURNAL ARTICLE
Langue :
Identificateurs : urn:issn:1465-5411 
info:doi/10.1186/bcr3481
info:pii/bcr3481
info:pmid/24060333